HomePharma

Pharma

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Life Sciences Times - April 30, 2026

Pharma

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

Life Sciences Times - April 30, 2026

Pharma

Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment

Life Sciences Times - April 30, 2026

Pharma

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

Life Sciences Times - April 29, 2026

Pharma

FDA Accepts New Drug Application for Zipalertinib in EGFR-Mutated Lung Cancer

Life Sciences Times - April 28, 2026

Pharma

Alnylam to Launch Global Phase 3 Trial of Zilebesiran After KARDIA-3 Study

Life Sciences Times - August 30, 2025 0

Pharma

Enveric Biosciences Completes Key Preclinical Studies for EB-003, Paving Way Toward Human Trials

Life Sciences Times - August 28, 2025 0

Pharma

Amylyx Ends ORION Trial of AMX0035 in Progressive Supranuclear Palsy After Failing to Show Benefit

Life Sciences Times - August 27, 2025 0

Pharma

Calluna Pharma Begins Phase 2 AURORA Trial of CAL101 for Idiopathic Pulmonary Fibrosis

Life Sciences Times - August 26, 2025 0

Pharma

Cambrex Expands Peptide Manufacturing Capabilities at Waltham, Massachusetts Facility

Life Sciences Times - August 25, 2025 0

Pharma

Merz Therapeutics Begins Phase III Trials of XEOMIN® for Migraine Prevention

Life Sciences Times - August 25, 2025 0

Pharma

Stoke Therapeutics and Biogen Share New Data on Zorevunersen for Dravet Syndrome at International Epilepsy Congress

Life Sciences Times - August 25, 2025 0

Pharma

SMSbiotech Launches First-in-Human Clinical Trial for COPD Stem Cell Therapy

Life Sciences Times - August 22, 2025 0

Pharma

Sensory Cloud Reports Positive Phase 2a Results for SC0023 in Patients With Refractory Chronic Cough

Life Sciences Times - August 20, 2025 0

Pharma

Aldeyra Therapeutics Secures FDA Fast Track Status for Retinitis Pigmentosa Therapy

Life Sciences Times - August 19, 2025 0

Pharma

Kelonia Therapeutics Begins First-in-Human Trial of In Vivo CAR-T Therapy for Multiple Myeloma

Life Sciences Times - August 19, 2025 0

Pharma

GoodRx Partners with Novo Nordisk to Offer Ozempic and Wegovy for $499 Per Month

Life Sciences Times - August 18, 2025 0

1...131415...91 Page 14 of 91

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

April 30, 2026

Johnson & Johnson Names Ryan Koors Vice President of Investor Relations

April 30, 2026

Moleculent Raises $20 Million to Expand Functional Profiling Platform

April 30, 2026

Komodo Health Names Paul Thomas Chief Financial Officer

April 30, 2026

Pharma

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

FDA Accepts New Drug Application for Zipalertinib in EGFR-Mutated Lung Cancer

Most Read

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Johnson & Johnson Names Ryan Koors Vice President of Investor Relations

Moleculent Raises $20 Million to Expand Functional Profiling Platform

Komodo Health Names Paul Thomas Chief Financial Officer

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

LightForce Launches Patient-Specific 3D-Printed Metal Braces

Fujifilm Executive Taisuke Fujita Receives ASGE Crystal Award for Contributions to Endoscopic Care

Cerus Signs Four-Year Supply Deal With French Blood Agency for INTERCEPT System

POPULAR CATEGORY

ABOUT US

FOLLOW US